Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:50 PM
Ignite Modification Date:
2025-12-24 @ 4:50 PM
NCT ID:
NCT01285050
Eligibility Criteria:
Inclusion Criteria:
* Adult Human
* Able to provide written informed consent
* HIV antibody positive
* HIV viral load positive
* HIV treatment naive
* Hepatitis C antibody positive
* Hepatitis C viral load positive
* Hepatitis C treatment naive
* Approved to take HIV medications for minimum 9 months
* Willing to use contraception, Life expectancy greater than 2 years
Exclusion Criteria:
* Significant opportunistic infections within 12 month
* Hepatitis B positive
* Evidence of liver cirrhosis
* Decompensated liver disease
* Chronic alcohol abuse
* Allergy to raltegravir, tenofovir, and/or emtricitabine
* Active or suspected malignancy
* Sarcoidosis
* Active TB
* Coronary artery disease
* Uncontrolled seizures
* Untreated thyroid disease
* Untreated diabetes
* Weight greater than 125 kg
* Severe depression or severe psychiatric disorder
* Ongoing alcohol or illicit drug use
* Pregnant, nursing, pr planning to become pregnant
* Allergy to interferon
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT01285050
Study Brief:
Protocol Section:
NCT01285050